FDA Names New Leaders for Key Centers | Durham News

The FDA just landed its new permanent leadership team, bringing stability after a whirlwind year of departures and controversies. Dr. Michael Davis, a psychedelic drug expert, now heads the largest division reviewing new psychiatric treatments. Karim Mikhail, a seasoned pharmacist and ex-pharma exec, takes the reins at the vaccines center. Bret Koplow steps into the tobacco director role, while Jared Seehafer is tapped to lead AI and tech initiatives — all aimed at steering the agency through complex scientific and regulatory waters with renewed clarity. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/158debff2f47139e